Home » Newsletters » BioWorld

BioWorld

April 15, 1993

View Archived Issues

DNAP EXPANDS TEST MARKETS FOR ITS VINESWEET TOMATO

EDITEK'S ONE-STEP ASSAY RECEIVES PATENT

IMCLONE GETS LICENSE TO EGFR MABS

SANDOZ SELLS HUMAN MAbs TO PDL FOR $5 MILLION

SANDOZ AND SYSTEMIX TEAM UP FOR AIDS GENE THERAPY

CALGENE WILL LABEL ITS ANTISENSE TOMATO

GREENWICH FILES PLA

LIFECELL GETS SBIR GRANT

CELLTECH TO BUILD MANUFACTURING FACILITY IN N.H.

PPTI GETS PATENT FOR BETASILK

SANDOZ LICENSES BTG'S AMINOPEPTIDASE

ARMY TRANSFERS AIDS TRIAL FUNDS TO DHHS

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...